1. FRI0363 KL6 and not CCL-18 is a predictor of early progression in systemic sclerosis related interstitial lung disease. (15th June 2017) Authors: Salazar, G; Kuwana, M; Wu, M; Estrada-Y-Martin, RM; Ying, J; Charles, J; Bellocchi, C; Mayes, M; Assassi, S Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0126 A phase 2 study of safety and efficacy of anabasum (JBT-101) in systemic sclerosis. (15th June 2017) Authors: Spiera, R; Hummers, L; Chung, L; Frech, T; Domsic, R; Furst, D; Gordon, J; Mayes, M; Simms, R; Constantine, S; White, B Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development. (22nd February 2011) Authors: Broen, J C A; Gourh, P; Vonk, M C; Beretta, L; Niederer, F; Rueda, B; Geurts-van Bon, L; Brouwer, C; Hesselstrand, R; Herrick, A; Worthington, J; Hunzelman, N; Fonseca, Denton C; Riemekasten, G; Kiener, H; Scorza, R; Simeon, C P; Fonollosa, V; Carreira, P; Ortego-Centeno, N Journal: Annals of the rheumatic diseases Issue: Volume 70(2011)Supplement 2 Page Start: A19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗